Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Mutations

Mutations

Translation

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt-Jakob Disease MV1 Subtype.

Neuropathology and applied neurobiology·2026

Same author

Gangliosides modulate the secretion of extracellular vesicles and their misfolded protein cargo.

Science advances·2025

Same author

Temperature-Dependent Aggregation of Tau Protein Is Attenuated by Native PLGA Nanoparticles Under in vitro Conditions.

International journal of nanomedicine·2025

Same author

Distinct patterns of prion strain deposition and toxicity in a novel whole brain organotypic slice culture system.

Scientific reports·2025

Same author

Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.

Scientific reports·2024

Same author

Rational design of structure-based vaccines targeting misfolded alpha-synuclein conformers of Parkinson's disease and related disorders.

Bioengineering & translational medicine·2024

Same journal

Correction.

Prion·2026

Same journal

Early diagnosis of a case of Heidenhain variant of Creutzfeld-Jakob disease by cerebrospinal fluid real-time quaking-induced conversion test.

Prion·2026

Same journal

In memoriam of Pawel P. Liberski (1954-2025).

Prion·2026

Same journal

Maternal chronic wasting disease infection restricts fetal head size in white-tailed deer (<i>Odocoileus virginianus</i>).

Prion·2026

Same journal

Plaque-type dura mater graft-associated Creutzfeldt-Jakob disease: an autopsied case report.

Prion·2026

Same journal

Efficient induction of motor neuron disease in transgenic G93A SOD1 mice by prion-like seeding.

Prion·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 10, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Implications of prion polymorphisms.

Leonardo M Cortez¹, Valerie L Sim

¹Centre for Prions and Protein Folding Diseases; University of Alberta; Edmonton, AB Canada.

|June 29, 2013

Summary

This summary is machine-generated.

Prion protein gene (Prnp) polymorphisms influence prion disease susceptibility and strain propagation. Different Prnp variants affect prion aggregation and conformational adaptability, impacting disease incubation periods and strain diversification.

Keywords:

adaptation aggregation amyloid kinetics mouse polymorphism prion propagation species barrier strain

More Related Videos

Protein Misfolding Cyclic Amplification of Prions

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

Related Experiment Videos

Last Updated: May 10, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Protein Misfolding Cyclic Amplification of Prions

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

Area of Science:

Neuroscience
Molecular Biology
Genetics

Background:

Prion protein (PrP) sequence influences host susceptibility to prion diseases and the species barrier.
Prion protein gene (Prnp) polymorphisms exist within species, affecting susceptibility, incubation period, pathology, and phenotype.
These polymorphisms may influence the preferential propagation or generation of specific prion strains.

Purpose of the Study:

To investigate the impact of mouse Prnp(a) and Prnp(b) polymorphisms on prion protein aggregation, strain adaptability, and conformational variability.
To correlate in vitro findings with in vivo studies regarding incubation periods and strain propagation.
To understand the role of Prnp polymorphisms in prion strain diversification and interspecies transmission.

Main Methods:

In vitro analysis of aggregation tendency, strain adaptability, and conformational variability of PrP(a) and PrP(b).
Comparison of in vitro data with existing in vivo studies on Prnp(a) and Prnp(b) mice.
Analysis of prion strain propagation patterns and conformational changes in different Prnp backgrounds.

Main Results:

PrP(a) exhibits faster/more efficient aggregation, explaining shorter incubation periods in Prnp(a) mice.
PrP(b) demonstrates greater conformational adaptability, enabling faithful propagation of prion strains in Prnp(b) mice.
Prnp(a) mice tend to revert PrP(b) strains into PrP(a)-type strains due to fewer preferred conformations.

Conclusions:

Prnp polymorphisms are a significant factor in the preferential propagation of certain prion strains.
The conformational adaptability of PrP(b) is crucial for maintaining strain integrity.
These findings have critical implications for understanding prion disease spread, particularly chronic wasting disease (CWD), and potential interspecies transmission.